Early Data Show INCA033989 Activity in Calreticulin-Driven MyelofibrosisBySpencer FeldmanDecember 31st 2025
Rusfertide Maintains Hematocrit Control in Patients With Polycythemia Vera BySilas InmanDecember 31st 2025
Gedatolisib Plus Faslodex Shows Efficacy in Advanced HR+ Breast CancerByKristi RosaDecember 30th 2025
Reading the Fine Print: Why Ingredient Awareness Matters After CancerByBonnie AnnisDecember 30th 2025